Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
REAL WORLD EVIDENCE ON DRUG UTILIZATION PATTERNS OF ELTROMBOPAG IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: REVIEU (REVOLADE™ [ELTROMBOPAG] IN SELECTED COUNTRIES IN THE EUROPEAN UNION) STUDY
15 októbra, 2020 7:25 pmAuthor(s): Emilio Ojeda Gutiérrez, Abdulgabar Salama, Jean-François Viallard, et. al. Abstract: P 720 Session topic: 32. Platelets disorders...
Optimalizácia liečby imúnnej trombocytopénie a nové stratégie liečby trombocytopénie pri aplastickej anémii a myelodysplastickom syndróme
15 októbra, 2020 7:25 pmNa tohtoročnom kongrese EHA odzneli viaceré prednášky na tému imúnnej trombocytopénie (ITP), jej patofyziológie, nových možností a optimalizácie jej liečby. ITP je získané...
PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE SHOW SIMILAR SURVIVAL PATTERNS AS LOW RISK MDS PATIENTS
15 októbra, 2020 7:25 pmAuthor(s): Jakob Werner Hansen, Maj Westman, Andreas Due Orskov, et. al. Abstract: S 486 Session topic: 10. Myelodysplastic...
A PHASE IB STUDY EVALUATING THE SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB ALONE AND IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH RELAPSED OR REFRACTORY MYELODYSPLASTIC SYNDROMES
15 októbra, 2020 7:25 pmAuthor(s): Aaron T. Gerds, Bart L. Scott, Peter Greenberg, et. al. Abstract: P 662 Session topic: 10. Myelodysplastic...
DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND NON-CLONAL CYTOPENIAS BY FLOW CYTOMETRY ANALYSIS USING A MYELOID MATURATION DATABASE
15 októbra, 2020 7:25 pmAuthor(s): M Teresa Cedena, Fátima Mirás, Rosa M Ayala, et. al Abstract: P 661 Session topic: 9. Myelodysplastic...
UPDATED RESULTS FROM PHASE 2 STUDY OF GUADECITABINE FOR PATIENTS WITH UNTREATED INT-2/HIGH RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA
15 októbra, 2020 7:25 pmAuthor(s): Guillermo Montalban-Bravo, Prithviraj Bose, Yesid Alvarado, et. al. Abstract: P 315 Session topic: 10. Myelodysplastic syndromes –...
Myelodysplastický syndróm
15 októbra, 2020 7:25 pmAbstrakt: Myelodysplastický syndróm (MDS) predstavuje skupinu klonálnych myeloidných ochorení, je charakterizovaný dysplastickými zmenami a inefektívnou hematopoézou, ktorá vedie k periférnej cytopénii so...
CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL
15 októbra, 2020 7:25 pmAuthor(s): Loretta Nastoupil, Matthew A. Lunning, Julie M. Vose, et. al. Abstract: S 772 Session topic: 6. Chronic...
IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA: UPDATED EFFICACY AND SAFETY OF THE RESONATE STUDY WITH UP TO FOUR YEARS OF FOLLOW-UP
15 októbra, 2020 7:25 pmAuthor(s): Carol Moreno, John C. Byrd, Peter Hillmen, et. al. Abstract: S 769 Session topic: 6. Chronic lymphocytic...
BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G, GA101) AND VENETOCLAX (A, ABT-199) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2-BAG PHASE-II-TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)
15 októbra, 2020 7:25 pmAuthor(s): Paula Cramer, Julia von Tresckow, Jasmin Bahlo, et. al. Abstract: S 464 Session topic: 6. Chronic lymphocytic...